Women’s Health Report Assesses first-in-class innovation with focus on endometriosis, polycystic ovarian syndrome and cervical intraepithelial neoplasia

This report assesses first-in-class innovation across the women’s health therapy area, with a particular focus on three key indications: endometriosis, polycystic ovarian syndrome (PCOS) and cervical intraepithelial neoplasia (CIN).

Pune, India - March 14, 2018 /MarketersMedia/ —

The women’s health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation, conception, pregnancy, childbirth and menopause. Many of these disorders are highly prevalent among the female population. Despite this, the women’s health market is relatively small. This reflects diagnostic barriers and high levels of non-treatment for women’s health disorders, as well as high levels of genericization and relatively limited innovation within recent decades.
Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-womens-health-an-expanding-therapy-area-with-endometriosis-therapies-prominent-among-the-first-in-class-pipeline
Scope
• Many women’s health disorders are highly prevalent. How do epidemiology trends vary for endometriosis, PCOS and CIN?
• Innovation within women’s health has been relatively limited over recent decades. What are the most prominent unmet needs across this therapy area?
• There are 261 pipeline programs in active development for women’s health. What proportion of these products are first-in-class? How does first-in-class innovation vary by indication, development stage and molecular target class?
• Although the first-in-class pipeline is relatively modest in size it is considerably diverse with eight distinct molecular target classes represented. Which first-in-class targets have been identified as most promising for women’s health conditions?
• Over 200 licensing deals relating to women’s health have been completed since 2006. Do women’s health products typically attract high deal values? Which first-in-class products have prior deal involvement?
Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/987871
Reasons To Buy
• Understand the current clinical and commercial landscape. This includes a comprehensive study of symptoms, epidemiology, etiology, pathophysiology, co-morbidities and complications, diagnosis and treatment options.
• Visualize the composition of the women’s health market in terms of dominant molecule types and molecular targets, highlighting what the current unmet needs are and how they can be addressed. This knowledge allows a competitive understanding of gaps in the current market.
• Analyze the women’s health pipeline and stratify by stage of development, molecule type and molecular target.
• Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising first-in-class targets have been reviewed in greater detail.
• Recognize commercial opportunities in the women’s health deals landscape by analyzing trends in licensing and co-development deals, and identifying women’s health therapies that have not yet been involved in deals and may offer potential investment opportunities.
Get this report at: https://www.themarketreports.com/report/buy-now/987871

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/womens-health-report-assesses-first-in-class-innovation-with-focus-on-endometriosis-polycystic-ovarian-syndrome-and-cervical-intraepithelial-neoplasia/314337

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-womens-health-an-expanding-therapy-area-with-endometriosis-therapies-prominent-among-the-first-in-class-pipeline%20%20

Source: MarketersMedia

Release ID: 314337

Latest News

Pompeo: No end to NKorea sanctions until 'denuclearization'

Sep 23, 2018

NEW YORK — Top U.S. diplomat Mike Pompeo said Sunday that economic sanctions on North Korea won't be reduced until it completes "denuclearization" after leader Kim Jong Un offered to close the North's main nuclear site in exchange for U.S. concessions. Kim said last week at a summit with South Korea's president that he was willing to dismantle the Nyongbyon nuclear complex in the presence of outside inspectors if the U.S. takes unspecified "corresponding measures." He also promised to dismantle the North's main rocket launch site. That has helped revive U.S.-North Korea diplomacy that had failed to make headway since...

At UN, unrepentant Trump set to rattle foes, friends alike

Sep 23, 2018

BRIDGEWATER, N.J. — President Donald Trump is poised to redouble his commitment to "America First" on the most global of stages this week. In the sequel to his stormy U.N. debut, Trump will stress his dedication to the primacy of U.S. interests while competing with Western allies for an advantage on trade and shining a spotlight on the threat that he says Iran poses to the Middle East and beyond. One year after Trump stood at the rostrum of the U.N. General Assembly and derided North Korea's Kim Jong Un as "Rocket Man," the push to denuclearize the Korean Peninsula...

Meghan reveals 'something blue' she wore at royal wedding

Sep 23, 2018

LONDON — It's an old tradition that a bride should have something old, something new, something borrowed and something blue on her wedding day, and the Duchess of Sussex followed at least part of that when she married Prince Harry. The former Meghan Markle has revealed in a television documentary that she had a piece of blue fabric from the dress she wore on her first date with Harry sewn into her wedding dress. She made the comments while discussing the dress in a documentary about Queen Elizabeth II called "Queen of the World." She didn't say whether she also...

Dolce&Gabbana explore DNA with star-filled cast

Sep 23, 2018

MILAN — Milan designers are embracing women of all shapes, sizes and ages, even if the young, thin model prevailed during this week's previews for next spring and summer. Marni's runway included women of different sizes while Dolce & Gabbana continued their embrace of models in a range of ages and sizes for their DNA runway show on Sunday. Highlights from Sunday's show, the fifth day of previews of womenswear for next spring and summer: DOLCE & GABBANA PAY TRIBUTE TO HERITAGE Dolce & Gabbana retraced their DNA by bringing back some of their most famous models: Carla Bruni in...

As aid checks go out, farmers worry bailout won't be enough

Sep 23, 2018

WASHINGTON — Farmers across the United States will soon begin receiving government checks as part of a billion-dollar bailout to buoy growers experiencing financial strain from President Donald Trump's trade disputes with China. But even those poised for big payouts worry it won't be enough. And while support for Trump is near unwavering in the heartland, some growers say that with the November election nearing, such disappointing aid outcomes could potentially affect their vote. "It's pretty obvious that the rural agriculture communities helped elect this administration, but the way things are going I believe farmers are going to have to...

Search

Obserworld delivers the most accurate and up-to-date world news for the global audience with a thorough research and in-depth interviews. Discover the world through Obserworld.

Contact us: sales[at]obserworld.com